A meta-analysis of the relationship between brain dopamine receptors and obesity: A matter of changes in behavior rather than food addiction

International Journal of Obesity

Volumn 40, Issue S1, 2016, Pages S12-S21

  Benton, D ^a   Young, H A ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; DOPAMINE 2 RECEPTOR; DRD2 PROTEIN, HUMAN;

ALLELE; BINGE EATING DISORDER; BODY MASS; BRAIN; FEEDING BEHAVIOR; FOOD ADDICTION; GENETIC ASSOCIATION; HUMAN; IMPULSIVENESS; META ANALYSIS; OBESITY; PRIORITY JOURNAL; REVIEW; WITHDRAWAL SYNDROME; ADDICTION; CRAVING; FOOD PREFERENCE; GENETICS; IMPEDANCE; METABOLISM; PATHOPHYSIOLOGY; PSYCHOLOGY; REWARD;

BEHAVIOR, ADDICTIVE; BRAIN; CRAVING; ELECTRIC IMPEDANCE; FEEDING BEHAVIOR; FOOD PREFERENCES; HUMANS; OBESITY; RECEPTORS, DOPAMINE D2; REWARD;

EID: 84961801303     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2016.9     Document Type: Review

References (70)

1. Brownell KD, Gold MS (eds). Food and Addiction. Oxford University Press: Oxford, UK, 2012.
2. Munafó MR, Matheson IJ, Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-Analysis of case-control studies and evidence of publication bias. Mol Psychiatry 2007; 12: 454-461.
3. Deng XD, Jiang H, Ma Y, Gao Q, Zhang B, Mu B et al. Association between DRD2/ANKK1 TaqIA polymorphism and common illicit drug dependence: evidence from a meta-Analysis. Hum Immunol 2015; 76: 42-51.
4. Verdejo-Garcia A, Clark L, Verdejo-Román J, Albein-Urios N, Martinez-Gonzalez JM, Gutierrez B et al. Neural substrates of cognitive flexibility in cocaine and gambling addictions. Br J Psychiatry 2015; 207: 158-164.
5. Munafo MR, Timpson NJ, David SP, Ebrahim S, Lawlor DA. Association of the DD2R gene Taq1A polymorphism and smoking behavior: a meta-Analysis and new data. Nicotine Tob Res 2009; 11: 64-76.
6. Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R. The dopamine D2 receptor as a major gene in obesity and height. Biochem Med Metab Biol 1993; 50: 176-185.
7. Blum K, Braverman ER, Wood RC, Gill J, Li C, Chen TJ et al. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics 1996; 6: 297-305.
8. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W et al. Brain dopamine and obesity. Lancet 2001; 357: 354-357.
9. Martinez D, Saccone PA, Liu F, Slifstein M, Olowska D, Grassetti A et al. Deficits in dopamine D2 receptors and pre-synaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry 2012; 71: 192-198.
10. Martinez D, Gil R, Slifstein M, Hwang D-R, Huang Y, Perez A et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychaitry 2005; 58: 779-786.
11. Fehr C, Yakushev I, Hohmann N, Buchholz HG, Landvogt C, Deckers H et al. Association of low striatal dopamine D2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry 2008; 165: 507-514.
12. Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y et al. Cocaine dependence and D2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 2004; 29: 1190-1202.
13. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158: 2015-2021.
14. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 2004; 23: 39-53.
15. Blum K, Febo M, McLaughlin T, Cronje FJ, Han D, Gold SM. Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)(TM) as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric. J Behav Addict 2014; 3: 149-156.
16. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor binding characteristics in alcoholism. Arch Gen Psychiatry 1991; 48: 648-654.
17. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998; 3: 256-260.
18. Jonsson EG, Nothen NM, Grunhage F, Farde L, Nakashima Y, Propping P et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999; 4: 290-296.
19. Stice E, Spoor S, Bohon C, Small DM. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008; 322: 449-452.
20. Ergun MA, Karaoguz MY, Koc A, Camurdan O, Bideci A, Yazici AC et al. The apolipoprotein E gene and Taq1A polymorphisms in childhood obesity. Genet Test Mol Biomarkers 2010; 14: 343-345.
21. Stice E, Yokum S, Bohon C, Marti N, Smolen A. Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DD2R and DRD4. Neuroimage 2010; 50: 1618-1625.
22. Roth CL, Hinney A, Schur EA, Elfers CT, Reinehr T. Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention. BMC Pediatr 2013; 13: 197.
23. Hardman CA, Rogers PJ, Timpson NJ, Munafó MR. Lack of association between DRD2 and OPRM1 genotypes and adiposity. Int J Obes 2014; 38: 730-736.
24. Yokum S, Marti CN, Smolen A, Stice E. Relation of the multilocus genetic composite reflecting high dopamine signaling capacity to future increases in BMI. Appetite 2015; 87: 38-45.
25. Duran-Gonzalez J, Ortiz I, Gonzales E, Ruiz N, Ortiz M, Gonzalez A et al. Association study of candidate gene polymorphisms and obesity in a young Mexican-American population from South Texas. Arch Med Res 2011; 42: 523-531.
26. Araz NC, Nacak M, Balci SO, Benlier N, Araz M, Pehlivan S. Childhood obesity and the role of dopamine D2 receptor and cannabinoid receptor-1 gene polymorphisms. Gen Test Mol Biomarkers 2012; 16: 1408-1412.
27. Aksyonova E, Seyitnazarova A, Solntsava A, Zagrebaeva O, Mikhno H, Sukalo A. Association analysis of the D2 dopamine receptor gene Taq IA polymorphisms in a cohort of Belarus morbidly obese children and adolescents. Endo Abst 2014; 35: 778.
28. Spitz MR, Detry MA, Pillow P, Hu YH, Amos CI, Hong WK et al. Variant alleles of the D2 dopamine receptor gene and obesity. Nutr Res 2000; 20: 371-380.
29. Thomas GN, Critchley JAJH, Tomlinson B, Cockram CS, Chan JC. Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol 2001; 55: 605-611.
30. Epstein LH, Wright SM, Paluch RA, Leddy JJ, Hawk Jr LW, Jaroni JL et al. Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am J Clin Nutr 2004; 80: 82-88.
31. Fang YJ, Thomas GN, Xu ZL, Fang JQ, Critchley JA, Tomlinson B. An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. Int J Cardiol 2005; 102: 111-116.
32. Nisoli E, Brunani A, Borgomainerio E, Tonello C, Dioni L, Briscini L et al. D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord 2007; 12: 91-96.
33. Epstein LH, Temple JL, Neaderhiser BJ, Salis R, Erbe RW, Leddy JJ. Food reinforcement, the dopamine D-2 receptor genotype, and energy intake in obese and nonobese humans. Behav Neurosci 2007; 121: 877-886.
34. Athanasoulia AP, Sievers C, Uhr M, Ising M, Stalla GK, Schneider HJ. The effect of the ANKK1/DRD2 Taq1A polymorphism on weight changes of dopaminergic treatment in prolactinomas. Pituitary 2014; 17: 240-245.
35. Morton LM, Wang SS, Bergen AW, Chatterjee N, Kvale P, Welch R et al. DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenet Genomics 2006; 16: 901-910.
36. Chen TJH, Blum K, Kaata G, Braverman E, Pullin D, Downs BV et al. Reviewing the role of putative candidate genes in ''Neurobesigenics'', a clinical subtype of Reward Deficiency Syndrome (RDS). Gene Ther Mol Biol 2007; 11A: 61-74.
37. Thomas GN, Tomlinson B, Critchley JA. Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension 2000; 36: 177-182.
38. Southon A, Walder K, Sanigorski AM, Zimmet P, Nicholson GC, Kotowicz MA et al. Taq IA and Ser311Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diabet Nutr Metab 2003; 16: 72-76.
39. Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C et al. Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder. Prog Neuro Psychopharmacol Biol Psychiatry 2008; 32: 620-628.
40. Noble EP, Noble RE, Ritchie T, Syndulko K, Bohlman MC, Noble LA et al. Allelic association of the human D2 dopamine receptor gene with obesity. Int J Eating Disord 1994; 15: 205-217.
41. Jenkinson CP, Hanson R, Cray K, Wiedrich C, Knowler WC, Bogardus C et al. Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA with obesity or type 2 diabetes mellitus in Pima Indians. Int J Obes 2000; 24: 1233-1238.
42. Barnard ND, Noble EP, Ritchie T, Cohen J, Jenkins DJ, Turner-McGrievy G et al. D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. Nutrition 2009; 25: 58-65.
43. Cameron JD, Riou ME, Tesson F, Goldfield GS, Rabasa-Lhoret R, Brochu M et al. The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women. Appetite 2013; 60: 111-116.
44. Davis C, Levitan RD, Yilmaz Z, Kaplan AS, Carter JC, Kennedy JL. Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes. Prog Neuropsychopharmacol Biol Psychiatry 2012; 38: 328-335.
45. Ariza M, Garolera M, Jurado MA, Garcia-Garcia I, Hernan I, Sánchez-Garre C et al. Dopamine genes (DRD2/ANKK1-TaqA1 and DRD4-7R) and executive function: their interaction with obesity. PLoS One 2012; 7: e41482.
46. Winkler JK, Woehning A, Schultz J-H, Brune M, Beaton N, Challa TD et al. TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients. Nutrition 2012; 28: 996-1001.
47. Carpenter Cl, Wong AM, Li Z, Noble EP, Heber D. Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity. Obesity 2013; 21: E467-E473.
48. Steele KE, Prokopowicz GP, Schweitzer MA, Magunsuon TH, Lidor AO, Kuwabawa H et al. Alterations of central dopamine receptors before and after gastric bypass surgery. Obes Surg 2010; 20: 369-374.
49. Eisenstein SA, Antenor-Dorsey JAV, Gredysa DM, Koller JM, Bihun EC, Ranck SA et al. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N?[11C] methyl) benperidol. Synapse 2013; 67: 748-756.
50. Kessler RM, Zald DH, Ansari MS, Li R, Cowan RL. Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity. Synapse 2014; 68: 317-320.
51. Karlsson HK, Tuominen L, Tuulari JJ, Hirvonen J, Parkkola R, Helin S et al. Obesity is associated with decreased ?-opioid but unaltered dopamine D2 receptor availability in the brain. J Neurosci 2015; 35: 3959-3965.
52. de Weijer BA, van de Giessen E, van Amelsvoort TA, Boot E, Braak B, Janssen IM et al. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. Eur J Nuc Med Mol Imaging Res 2011; 1: 37.
53. Haltia LT, Rinne JO, Helin S, Parkkola R, Någren K, Kaasinen V. Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse 2007; 61: 748-756.
54. Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J et al. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 2008; 42: 1537-1543.
55. Dunn JP, Kessler RM, Feurer ID, Volkow ND, Patterson BW, Ansari MS et al. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabet Care 2012; 35: 1105-1111.
56. Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD. Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry 2014; 19: 1078-1084.
57. Ratsma JE, Stelt O, Schoffelmeer AN, Westerveld A, Boudewijn Gunning W. P3 event-related potential, dopamine D2 receptor A1 allele, and sensation-seeking in adult children of alcoholics. Alcohol Clin Exp Res 2001; 25: 960-967.
58. Eisenberg DT, MacKillop J, Modi M, Beauchemin J, Dang D, Lisman SA et al. Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study. Behav Brain Functions 2007; 3: 2.
59. White MJ, Morris CP, Lawford BR, Young RM. Behavioral phenotypes of impulsivity related to the ANKK1 gene are independent of an acute stressor. Behav Brain Funct 2008; 24: 54-63.
60. Jocham G, Klein TA, Neumann J, von Cramon DY, Reuter M, Ullsperger M. Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. J Neurosci 2009; 29: 3695-3704.
61. Klein TA, Neumann J, Reuter M, Hennig J, von Cramon DY, Ullsperger M. Genetically determined differences in learning from errors. Science 2007; 318: 1642-1645.
62. Vandenbroeck P, Goossens J, Clemens M. Tackling Obesities: Futures Choices-Obesity System Atlas. Government Office for Science. Her Majesties Stationary Office: London, 2007.
63. Benton D. The plausibility of sugar addiction and its role in obesity and eating disorders. Clin Nutr 2010; 29: 288-303.
64. Hebebrand J, Albayrak O, Adan R, Antel J, Dieguez C, de Jong J et al. "Eating addiction", rather than "food addiction", better captures addictive-like eating behaviour. Neurosci Biobehav Rev 2014; 47: 295-306.
65. Sadler MJ, McNulty H, Gibson S. Sugar-fat seesaw: a systematic review of the evidence. Crit Rev Food Sci Nutr 2015; 55: 338-356.
66. Holt SH, Miller JC, Petocz P, Farmakalidis E. A satiety index of common foods. Eur J Clin Nutr 1995; 49: 675-690.
67. Drewnowski A. Energy density, palatability, and satiety: implications for weight control. Nutr Rev 1998; 56: 347-353.
68. World Health Organization (WHO). Diet, nutrition and the prevention of excess weight gain and obesity. Report of a Joint WHO/FAO Expert Consultation. WHO Technical Report Series No. 916. WHO: Geneva, 2003.
69. Epstein LH, Dearing KK, Erbe RW. Parent-child concordance of Taq1 A1 allele predicts similarity of parent-child weight loss in behavioral family-based treatment programs. Appetite 2010; 55: 363-366.
70. Davis CA, Levitan RD, Reid C, Carter JC, Kaplan AS, King N et al. Dopamine for 'wanting' and opioids for 'liking': a comparison of obese adults with and without binge eating. Obesity 2009; 17: 1220-1225.